Skip to playerSkip to main content
Former President Donald Trump has unveiled “TrumpRx”, a new portal aimed at helping Americans access prescription medications at lower prices. Speaking at a high-profile announcement, Trump claimed the initiative represents a historic win over pharmaceutical giants, including Eli Lilly and Novo Nordisk, promising to make critical medications, including weight-loss and diabetes drugs, more affordable. The portal is being positioned as part of Trump’s ongoing healthcare efforts, targeting high drug costs that have burdened patients nationwide. While details on implementation and rollout are still emerging, Trump touted the initiative as a major achievement for consumers and a challenge to big pharma pricing practices. The announcement comes amid heightened attention to prescription drug costs and healthcare reform in the United States, drawing reactions from political leaders, industry insiders, and the public.

#TrumpRx #Trump #PharmaNews #DrugPrices #Healthcare #EliLilly #NovoNordisk #PrescriptionDrugs #TrumpAnnouncement #WeightLossDrugs #DiabetesMedication #HealthcareReform #TrumpVictory

Category

🗞
News
Transcript
00:00The President, here, Chris Plump.
00:03And we have Steve — where's Steve?
00:05Is he here?
00:06Head of Public Relations for the White House.
00:11He's taking it.
00:14The United States is just 4 percent of the world's
00:17population and consumes only 13 percent of all
00:22prescription drugs, yet pharmaceutical companies
00:25make 75 percent of their profits from their
00:28American customer.
00:29I would say that's not so good, right?
00:34That's not exactly right.
00:35To address this chronic unfairness, I signed an
00:38executive order earlier this year instructing my
00:41administration to do everything in our power to
00:44implement most favored nations' drug pricing.
00:47Something that has been helped greatly by tariffs,
00:51because when nations refuse to do it — we should have
00:54put this in the case yesterday — I just say,
00:57well, if you're not going to do it, we're going to
00:58charge you a like amount of tariffs.
01:01And they immediately say, we'll do it.
01:04Which means that Americans should pay no more than the
01:06lowest price offered anywhere in the world.
01:10So that — you've heard for years the disparity
01:12where you'll pay $150 for a pill in New York and you'll
01:16pay $10 for a pill in London.
01:18Now you're going to pay $20, both — because the
01:21world is a little bit bigger than the U.S.
01:23so it goes up that way.
01:24But you'll pay $20 and $20.
01:27A tremendous advantage to our country after years of
01:32being abused by the world system.
01:35Already, Pfizer, AstraZeneca, and EMD, Serrano, have
01:40agreed to drastically lower their prices for American patients.
01:43And today, Eli Lilly and Novo Nordisk are joining the
01:49phenomenal list of the most exciting announcements.
01:53I mean, nobody has ever had announcements like — and
01:55this has to do with other pharmaceutical products also.
02:00But we're covering this today because it's such a big
02:02seller.
02:03I guess it's the number one selling thing there is today.
02:06These are two companies that are behind the
02:08groundbreaking weight loss drugs that have helped
02:11millions of Americans struggling with obesity,
02:14live better, longer lives, everything else.
02:16These are the two companies that really broke ground.
02:19Until now, neither of these two popular drugs have
02:22been covered by Medicare for weight loss, and they've
02:25only rarely been covered by Medicaid.
02:29They've often cost consumers more than $1,000 per month,
02:33and some a lot more than that.
02:36Americans have been spending as much as 520 percent more
02:40for ZepBound and 1,400 percent more for Wegovy than
02:46patients in Europe.
02:47Think of that.
02:481,400 percent more than a patient in Europe for the
02:50exact same box.
02:53And that ends starting today.
02:55The other countries are not happy with us.
02:58Now, I don't think they like me too much, Bobby,
03:00but that's okay.
03:01Eli Lilly and Novo Nordisk are committing to offer ZepBound
03:06and Wegovy at most favored nations rates for American patients.
03:11This will slash the cost of Wegovy from $1,350 a month
03:17to ultimately $250 a month.
03:20$1,350 to $250.
03:23Did I do a good job?
03:25They don't write about it.
03:26You know, they like to not write these things.
03:29And reduce — you think anybody — you think Biden
03:31could have done this?
03:32I don't think so.
03:33— and reduce the monthly cost of ZepBound from $1,080
03:38to $346.
03:41In addition, they're both committing that future
03:44GLP-1 weight loss drugs taken orally, which are
03:48currently under development, will be sold at no more
03:51than $149 per month.
03:54It's a massive — think of that.
03:56You go from $1,300 to $149 a month.
04:00We anticipate these new versions will be coming out
04:04in a very short period of time.
04:06All of these drugs will be available directly to the
04:09consumer at TrumpRx.gov.
04:13Trump — they won't use my name.
04:15Trump — it better be good.
04:17TrumpRx.gov.
04:19And I think it's turning out to be pretty amazing, right?
04:21Just as significantly, Medicare and Medicaid will
04:26finally cover the cost of these weight loss drugs
04:29for millions of patients suffering from obesity.
04:33Co-pays for Medicare patients will be as low as $50.
04:38This is tremendous savings.
04:41I mean, now you're talking about from $1,350 to $50.
04:47This is tremendous news for the American seniors.
04:49And you all remember when I had one-eighth of 1 percent
04:53for the year — I cut it — one-eighth of it.
04:55And I was so thrilled.
04:56But now we're cutting it 1,000 percent, 1,200 percent.
05:00Nobody has ever seen anything like this.
05:02Nobody else could have done it, but I say that modestly.
05:06In addition, you think it was easy dealing with these people?
05:09It wasn't.
05:10You think it was easy saying,
05:13your drug, Mr. Eli Lilly, that we're selling for 1,300
05:16is going to be sold for 250.
05:19You know the amazing thing?
05:20The stocks all went up.
05:21I mean, these guys are — they're fantastic.
05:24Because it's going to equalize the world.
05:28The world is a bigger place, and it's going to equalize.
05:32I was a little surprised to see that,
05:33but I'm happy about it.
05:34In addition, Eli Lilly and Novo Nordisk
05:37have agreed to provide all of their other medications
05:40to Medicaid at most favored nations' prices —
05:43most favored nations,
05:45meaning that you will pay the lowest price anywhere in the world.
05:49That's what you're going to pay.
05:50Whereas, before, they paid low prices,
05:52and we paid, you know, thousands of percentile ahead more.
05:59And to sell these drugs to all consumers
06:01at deeply discounted prices via TrumpRx.com.
06:06When is TrumpRx.com opening?
06:08The President Trump is opening.
06:09It will launch in terms of giving people prices
06:12before the end of the year.
06:13The President Trump has got my name on it.
06:17I don't want to be like so many others.
06:19I don't want to be like the train
06:21they're building in California, okay?
06:23Which has about 15,000 percent cost to overrun.
06:28Or the Obama — the beautiful Obama building
06:31that he's building in Chicago for the museum,
06:35which has now shuttered up and dead.
06:38They got it up, and they couldn't finish.
06:41It's about, would you say, five years behind schedule?
06:44The President Trump had about 2,000 percent over budget.
06:47Then he tells us how to run Medicaid.
06:50Many of the most widely used drugs will be available for 60 percent off,
06:55or even more than that.
06:57In addition, all new medications introduced by Eli Lilly and Novo Nordisk
07:04to the American market will be sold at the heavily reduced,
07:08most favored nation's price.
07:10Most favored nation's price, that's the best.
07:13Because they have been thousands of percent lower
07:17than what we were selling, in many cases.
07:20Furthermore, Eli Lilly is investing $27 billion.
07:23That's all, and Novo Nordisk will invest $10 billion.
07:28That's all, that's peanuts, in the United States to reshore
07:33and do a big domestic manufacturing job in the facilities.
07:39They're going to spend — so Eli Lilly spent $27 billion.
07:43Novo is spending $10 billion in the United States.
07:46So they're building new plant and equipment.
07:50That's part of what will be $20 or $21 trillion this year.
07:55There's never been anything like it.
07:57I know nobody talks about it.
07:59But there's never been anything like —
08:00I would say you would say that there's never been anything like this,
08:04ever in — whether it's China or Europe,
08:07or you could take all of Europe,
08:09there's never been anything like this.
08:11So we're already past $17 trillion.
08:13We're going to be, I think, by the time the year closes out,
08:16we'll have investments of over $21 trillion,
08:19based on the way we're going.
08:20And — and by the way, tariffs are very important.
08:23Without tariffs, perhaps it could be a little bit different,
08:27to put it mildly. Tariffs are so important.
08:30The decision in the Supreme Court would be devastating to our country
08:35if we got a negative — devastating if we got a negative decision.
08:40But this is a great day for American health
08:43and health care and for all of American patients.
08:46These are things that are miracles to have this happen.
08:49And they're — you know, we're bringing all our medicines again
08:52because of tariffs. We're bringing all our medicines.
Comments

Recommended